Business Segments Cipla Limited

Stocks

CIPLA

INE059A01026

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 15:05:07 24/07/2026 +04			5-day change	1st Jan Change
1,410.60 ^INR	+1.26%		-0.57%	-6.66%

07-24	Jefferies Adjusts Cipla's Price Target to INR1,170 From INR1,120, Keeps at Underperform	MT
07-23	Cipla Limited, Q1 2027 Earnings Call, Jul 23, 2026

Sales 2026 by Business Segment

© MarketScreener.com See more

Sales 2026 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (INR)

Fiscal Period: March	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Pharmaceutical Products
Pharmaceutical and Related Products						214B	220B	248B	264B	278B
Total Assets						-	-	-	-	425B
Interest Expense						-	-	-	-	-482M
Income Tax Expense						-	-	-	-	13.54B
CAPEX						-	-	-	-	-15.99B
EBT						-	-	-	-	52.24B
D&A						-	-	-	-	10.72B
Operating Income						39.44B	43.83B	60.56B	68.72B	-
Net Income						-	-	-	-	38.79B
New Ventures						5.32B	10.55B	11.12B	13.03B	-
Operating Income						-1.62B	-528M	-691M	105M	-
Inter Segment Revenue						-1.19B	-3.01B	-1.8B	-2.02B	-

Geographical Revenue Distribution History

Geographical breakdown of sales (INR)

Fiscal Period: March	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
India						98.28B	98.69B	109B	116B	127B
Total Assets						47.8B	50.23B	51.96B	59.69B	81.08B
United States of America						44.31B	59.09B	75.02B	78.99B	68.72B
Total Assets						29.57B	31.59B	33.2B	34.82B	40.44B
Rest of The World						48.72B	46.41B	49.69B	42.07B	43.25B
Total Assets						9.04B	5.58B	4.72B	3.94B	5.19B
South Africa						26.33B	23.35B	24.31B	38.26B	42.85B
Total Assets						20.27B	17.71B	20.69B	21.65B	24.63B

As early as today, start finding the best investment opportunities!